Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials

od McCarthy, Patrick M., Valdera, Franklin A., Smolinsky, Todd R., Adams, Alexandra M., O’Shea, Anne E., Thomas, Katryna K., Van Decar, Spencer, Carpenter, Elizabeth L., Tiwari, Ankur, Myers, John W., Hale, Diane F., Vreeland, Timothy J., Peoples, George E., Stojadinovic, Alex, Clifton, Guy T.
Izdano 2023

Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinic...

od Adams, Alexandra M., Carpenter, Elizabeth L., Clifton, Guy T., Vreeland, Timothy J., Chick, Robert C., O’Shea, Anne E., McCarthy, Patrick M., Kemp Bohan, Phillip M., Hickerson, Annelies T., Valdera, Franklin A., Tiwari, Ankur, Hale, Diane F., Hyngstrom, John R., Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Shaheen, Montaser F., Yu, Xianzhong, Wagner, Thomas E., Faries, Mark B., Peoples, George E.
Izdano 2022

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis

od Carpenter, Elizabeth Lee, Van Decar, Spencer, Adams, Alexandra M, O’Shea, Anne E, McCarthy, Patrick, Chick, Robert Connor, Clifton, Guy Travis, Vreeland, Timothy, Valdera, Franklin A, Tiwari, Ankur, Hale, Diane, Kemp Bohan, Phillip, Hickerson, Annelies, Smolinsky, Todd, Thomas, Katryna, Cindass, Jessica, Hyngstrom, John, Berger, Adam C, Jakub, James, Sussman, Jeffrey J, Shaheen, Montaser F, Yu, Xianzhong, Wagner, Thomas E, Faries, Mark, Peoples, George E
Izdano 2023